Corcept Therapeutics Incorporated (CORT) is in Healthcare, Biotechnology, based in United States, listed on NasdaqCM. Market cap 12.81B USD. 52-week range 28.66 to 126.38 USD. Trailing P/E 263.4. Data as of 2026-10-09.
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for ...